Skip to main
SGHT
SGHT logo

Sight Sciences (SGHT) Stock Forecast & Price Target

Sight Sciences (SGHT) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 29%
Buy 0%
Hold 57%
Sell 14%
Strong Sell 0%

Bulls say

Sight Sciences Inc. has demonstrated a robust financial position with a gross margin of 86.8%, reflecting a year-over-year increase of 160 basis points and outperforming consensus estimates. Additionally, the company's expansion in ordering facilities, rising to 1,138, indicates a positive trajectory in operational growth, supported by anticipated gains in the minimally invasive glaucoma surgery (MIGS) market and accelerated adoption of the TearCare System. Furthermore, the forecasted revenue for 4Q24 of $18.9–19.1 million, along with the potential for profitability and sustained growth in the Surgical Glaucoma segment, presents a favorable outlook for the company’s future financial performance.

Bears say

Sight Sciences Inc. has exhibited disappointing financial performance, particularly within its Dry Eye segment, which reported revenue of $0.3 million, missing the consensus estimate of $0.4 million, despite an 81% year-over-year increase. The company’s overall revenue outlook for 1Q25 suggests a significant contraction, projected to decline by low- to mid-double digits year-over-year, further exacerbated by the negative impact of recently implemented Local Coverage Determinations (LCDs) on the OMNI Surgical System's utilization. Furthermore, the downward revisions of GAAP EPS estimates for 2025 and 2026—reducing forecasts to ($1.21) and ($1.03) respectively—underscore the anticipated challenges in revenue growth due to reimbursement headwinds.

Sight Sciences (SGHT) has been analyzed by 7 analysts, with a consensus rating of Hold. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 57% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sight Sciences and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sight Sciences (SGHT) Forecast

Analysts have given Sight Sciences (SGHT) a Hold based on their latest research and market trends.

According to 7 analysts, Sight Sciences (SGHT) has a Hold consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.16, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.16, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sight Sciences (SGHT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.